Economic impact of childhood/adolescent ADHD in a European setting: The Netherlands as a reference case

European Child and Adolescent Psychiatry

Volumn 23, Issue 7, 2014, Pages 587-598

  Le, Hoa H ^a   Hodgkins, Paul ^b   Postma, Maarten J ^a   Kahle, Jennifer ^c   Sikirica, Vanja ^b   Setyawan, Juliana ^b   Erder, M Haim ^b   Doshi, Jalpa A ^d  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b SHIRE   (United States)

^c BPS International   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adolescents; Attention deficit hyperactivity disorder; Children; Cost of illness; Societal costs

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ATTENTION DEFICIT DISORDER; BELGIUM; CHILD; CHILDHOOD DISEASE; COST OF ILLNESS; EMPLOYMENT; FAMILY; GERMANY; HEALTH CARE COST; HUMAN; INCOME; NETHERLANDS; PATIENT EDUCATION; PREVALENCE; PRODUCTIVITY; REVIEW; SENSITIVITY ANALYSIS; SOCIAL WORK; SWEDEN; SYSTEMATIC REVIEW; UNITED KINGDOM;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COST OF ILLNESS; FEMALE; HUMANS; MALE; NETHERLANDS; PREVALENCE;

EID: 84904722965     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-013-0477-8     Document Type: Review

References (62)

1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Text revision. American Psychiatric Association, Washington D.C.
2. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12(Suppl 1):1-27
3. Barkley RA, Guevremont DC, Anastopoulos AD, DuPaul GJ, Shelton TL (1993) Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 92:212-218 (Pubitemid 23226834)
4. Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR (2005) Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 21:195-206
5. Braun S, Zeidler J, Linder R, Engel S, Verheyen F, Greiner W (2012) Treatment costs of attention deficit hyperactivity disorder in Germany. Eur J Health Econ (Epub ahead of print)
6. Brod M, Pohlman B, Lasser R, Hodgkins P (2012) Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes 10:47
7. Danckaerts M, Sonuga-Barke EJ, Banaschewski T, Buitelaar J, Dopfner M, Hollis C, Santosh P, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Zuddas A, Coghill D (2010) The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 19:83-105
8. De Ridder A, De Graeve D (2006) Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium. Clin Drug Investig 26:75-90 (Pubitemid 43275701)
9. de Zwaan M, Gruss B, Muller A, Graap H, Martin A, Glaesmer H, Hilbert A, Philipsen A (2012) The estimated prevalence and correlates of adult ADHD in a German community sample. Eur Arch Psychiatry Clin Neurosci 262:79-86
10. Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, Erder MH, Neumann PJ (2012) Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry 51:990.e2-1002.e2
11. Edbom T, Lichtenstein P, Granlund M, Larsson JO (2006) Long-term relationships between symptoms of attention deficit hyperactivity disorder and self-esteem in a prospective longitudinal study of twins. Acta Paediatr 95:650-657 (Pubitemid 43879557)
12. European Commission Eurostat Labor Force Survey. http://epp.eurostat.ec. europa.eu/tgm/refreshTableAction.do?tab=table&plugin=1&pcode= tsdec420&language=en. Accessed 1 March 2013
13. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lepine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402-409 (Pubitemid 46706952)
14. Federal Reserve Economic Data from the Federal Reserve Bank of St. Louis. http://research.stlouisfed.org/fred2/series/EDUHEANLM086NEST. Accessed 10 April 2013
15. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H (2001) Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 108:71-78 (Pubitemid 32592007)
16. Hakkaart-van Roijen L, Zwirs BW, Bouwmans C, Tan SS, Schulpen TW, Vlasveld L, Buitelaar JK (2007) Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 16:316-326 (Pubitemid 47305457)
17. Higgins J, Green S (2009) Cochrane handbook for systematic reviews of interventions version 5.0.2. The Cochrane Collaboration. www.cochrane-handbook. org. Accessed 3 August 2012
18. Hodgkins P, Arnold LE, Shaw M, Caci H, Kahle J, Woods AG, Young S (2011) A systematic review of global publication trends regarding long-term outcomes of ADHD. Front Psychiatry 2:84
19. Hodgkins P, Montejano L, Sasane R, Huse D (2011) Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 13:e1-e12
20. Hodgkins P, Sasane R, Meijer WM (2011) Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 33:188-203
21. Hodgkins P, Setyawan J, Mitra D, Davis K, Quintero J, Shaw M, Harpin V (2013) Management of ADHD in children across Europe: patient demographics, physician characteristics, and treatment assessments. Eur J Pediatr 172:895-906
22. Huss M, Holling H, Kurth BM, Schlack R (2008) How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry 17(Suppl 1):52-58
23. Karaahmet E, Konuk N, Dalkilic A, Saracli O, Atasoy N, Kurcer MA, Atik L (2013) The comorbidity of adult attention-deficit/ hyperactivity disorder in bipolar disorder patients. Compr Psychiatry 54:549-555
24. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716-723 (Pubitemid 44464584)
25. Klassen AF, Miller A, Fine S (2004) Health-related quality of life in children and adolescents who have a diagnosis of attentiondeficit/hyperactivity disorder. Pediatrics 114:e541-e547 (Pubitemid 41655750)
26. Knapp M, King D, Healey A, Thomas C (2011) Economic outcomes in adulthood and their associations with antisocial conduct, attention deficit and anxiety problems in childhood. J Ment Health Policy Econ 14:137-147
27. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC (2001) Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 285:60-66 (Pubitemid 32042717)
28. Lichtenstein P, Halldner L, Zetterqvist J, Sjolander A, Serlachius E, Fazel S, Langstrom N, Larsson H (2012) Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 367:2006-2014
29. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565-576 (Pubitemid 23203567)
30. Mash EJ, Johnston C (1983) Parental perceptions of child behavior problems, parenting self-esteem, and mothers' reported stress in younger and older hyperactive and normal children. J Consult Clin Psychol 51:86-99 (Pubitemid 14200176)
31. Merrill RM, Lyon JL, Baker RK, Gren LH (2009) Attention deficit hyperactivity disorder and increased risk of injury. Adv Med Sci 54:20-26
32. Molina BS, Pelham WE Jr (2003) Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 112:497-507 (Pubitemid 36959375)
33. Mugno D, Ruta L, D'Arrigo VG, Mazzone L (2007) Impairment of quality of life in parents of children and adolescents with pervasive developmental disorder. Health Qual Life Outcomes 5:22
34. Murphy KR, Barkley RA (1996) Parents of children with attention-deficit/hyperactivity disorder: psychological and attentional impairment. Am J Orthopsychiatry 66:93-102 (Pubitemid 126500934)
35. Myren KJ, Thernlund G, Nylen A, Schacht A, Svanborg P (2010) Atomoxetine's effect on societal costs in Sweden. J Atten Disord 13:618-628
36. NationMaster. http://www.nationmaster.com/country/gm-germany/Age-- distribution. Accessed 1 March 2013
37. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B (2012) The economic cost of brain disorders in Europe. Eur J Neurol 19:155-162
38. Olesen J, Leonardi M (2003) The burden of brain diseases in Europe. Eur J Neurol 10:471-477 (Pubitemid 38028611)
39. Organisation for Economic Co-Operations and Development (OECD) Labour data on working hours. http://stats.oecd.org/Index.aspx?DatasetCode=ANHRS. Accessed 4 April 2013
40. Organisation for Economic Co-Operations and Development (OECD) Purchasing power parities for GDP. http://stats.oecd.org/Index.aspx?DataSetCode=SNA- TABLE4. Accessed 1 March 2013
41. Organisation for Economic Co-Operations and Development (OECD) SF1.1 Family size and composition. http://www.oecd.org/social/soc/oecdfamilydatabase. htm. Accessed 1 March 2013
42. Organisation for Economic Co-Operations and Development (OECD) SF1.4: Population by age of children and young adults, and youth-dependency ratio. http://www.oecd.org/els/family/SF1. 4%20Population%20by%20age%20of%20children%20and%20youth%20dependency%20ratio%20- %20update%20021112.pdf. Accessed 1 March 2013
43. Petrou S, Johnson S, Wolke D, Hollis C, Kochhar P, Marlow N (2010) Economic costs and preference-based health-related quality of life outcomes associated with childhood psychiatric disorders. Br J Psychiatry 197:395-404
44. Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894-921
45. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948 (Pubitemid 46972911)
46. Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E (2013) Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 29:1093-1104
47. Ray GT, Levine P, Croen LA, Bokhari FA, Hu TW, Habel LA (2006) Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch Pediatr Adolesc Med 160:1063-1069 (Pubitemid 44520637)
48. Satterfield JH, Faller KJ, Crinella FM, Schell AM, Swanson JM, Homer LD (2007) A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry 46:601-610 (Pubitemid 46642577)
49. Schöffski O, Sohn S, Happich M (2008) Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD). Gesundheitswesen 70:398-403
50. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE (2012) A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 10:99
51. Shilon Y, Pollak Y, Aran A, Shaked S, Gross-Tsur V (2012) Accidental injuries are more common in children with attention deficit hyperactivity disorder compared with their non-affected siblings. Child Care Health Dev 38:366-370
52. Sourander A, Elonheimo H, Niemela S, Nuutila AM, Helenius H, Sillanmaki L, Piha J, Tamminen T, Kumpulainen K, Moilenen I, Almqvist F (2006) Childhood predictors of male criminality: a prospective population-based follow-up study from age 8 to late adolescence. J Am Acad Child Adolesc Psychiatry 45:578-586
53. Spencer TJ, Biederman J, Mick E (2007) Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambul Pediatr 7:73-81
54. Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A (2003) Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 42:1415-1423 (Pubitemid 39585971)
55. Telford C, Green C, Logan S, Langley K, Thapar A, Ford T (2012) Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder. Soc Psychiatry Psychiatr Epidemiol 48:337-344
56. US Centers for Disease Control (2010) Increasing prevalence of parent reported attention-deficit/hyperactivity disorder among children-United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 59:1439-1443
57. Van der Oord S, Van der Meulen EM, Prins PJ, Oosterlaan J, Buitelaar JK, Emmelkamp PM (2005) A psychometric evaluation of the social skills rating system in children with attention deficit hyperactivity disorder. Behav Res Ther 43:733-746 (Pubitemid 40693698)
58. Wehmeier PM, Schacht A, Rothenberger A (2009) Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years. Child Adolesc Psychiatry Ment Health 3:3
59. Willcutt EG (2012) The prevalence of DSM-IV attention-deficit/ hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9:490-499
60. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF (2005) Validity of the executive function theory of attentiondeficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57:1336-1346 (Pubitemid 40798553)
61. World Health Organization (2008) ICD-10: International statistical classification of diseases and related health problems, 10th rev. edn. WHO, New York
62. Young J (2008) Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 19:216-228, vii